From Beijing to 40+ Countries: AK Medical's Journey in Numbers

AK Medical Holdings Limited began in 2003 as a Beijing orthopedic implant manufacturer. Two decades later it is the world's first company to commercialize 3D-printed orthopedic implants, listed on the Hong Kong Stock Exchange, and trusted by more than 7,500 hospitals. Here is the journey in numbers.

Timeline of key milestones

Year	Milestone
2003	Founded in Beijing, Changping Science Park
2015	NMPA (CFDA) approves China's first 3D-printed orthopedic implant — AK Medical's acetabular cup
2017	IPO on the Main Board of the Hong Kong Stock Exchange (stock code 01789.HK)
2018	Acquisition of JRI Orthopaedics Ltd. (Sheffield, UK), adding Supravit™ coating technology and 50+ years of clinical heritage
2020	Acquisition of Beijing Libeier, expanding into spine and trauma implants
Today	1.2M+ implants delivered, 7,500+ partner hospitals, 40+ countries, 600+ patents

The technology portfolio behind the growth

• 3DACT™ — proprietary 3D printing precision building technology; 210+ patents
• Supravit™ — vacuum plasma spray hydroxyapatite coating (JRI Orthopaedics, Queen's Award for Technology)
• One Point™ — surgical navigation and robotic assistance platform
• ICOS™ — end-to-end custom implant pathway, ~1,000 complex cases completed

Regulatory footprint

AK Medical products carry approvals across major markets:

• NMPA Class III registrations in China (70+, the country's highest device tier)
• CE Mark for the EU/EEA
• FDA 510(k) clearances for the United States

Group structure

The group today spans four operating companies:

1. Beijing AKEC Medical — flagship manufacturing and R&D, Beijing
2. ITI Medical (Changzhou) — instrument and implant production
3. JRI Orthopaedics — UK-based R&D, manufacturing and Supravit™ coatings
4. Beijing Libeier — spine and trauma implant specialist

For investor materials, corporate governance information and HKEX filings, see the Investor Relations section, or contact us directly.